Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chimerix

8.43
-0.0300-0.35%
Volume:5.28M
Turnover:44.55M
Market Cap:758.16M
PE:-8.98
High:8.44
Open:8.43
Low:8.42
Close:8.46
Loading ...

Company Profile

Company Name:
Chimerix
Exchange:
NASDAQ
Establishment Date:
2000
Employees:
72
Office Location:
2505 Meridian Parkway,Suite 100,Durham,North Carolina,United States
Zip Code:
27713
Fax:
919 806 1146
Introduction:
Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases. Its pipeline products include ONC201 a program that is in Phase 3 clinical trial for treating patients with H3 K27M-mutant diffuse glioma, as well as in Phase 2 clinical trial for the treatment of rare neuroendocrine tumors; and ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist, which is in Phase 1 clinical trial for adult and pediatric patients with primary central nervous system tumors. The company also develops ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for oncology indications; and CMX521, a nucleoside analog antiviral drug candidate for the treatment of SARS-CoV-2. It has license agreement with SymBio Pharmaceuticals to develop and commercialize TEMBEXA for human diseases other than orthopoxviruses, including smallpox. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

Directors

Name
Position
M. Michelle Berrey
Director,President and Chief Executive Officer
C. Patrick Machado
Director
Catherine L. Gilliss
Director
Ernest Mario
Director
James M. Daly
Director
James Niedel
Director
John M. Leonard
Director
Lisa Ricciardi
Director
Martha J. Demski
Director
Ronald C. Renaud, Jr.
Director
Timothy J. Wollaeger
Director

Shareholders

Name
Position
M. Michelle Berrey
Director,President and Chief Executive Officer
Timothy W. Trost
Senior Vice President, Chief Financial Officer and Corporate Secretary
Linda Richardson
Chief Commercial Officer
Michael D. Rogers
Chief Development Officer
W. Garrett Nichols
Chief Medical Officer